nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—MAP2K1—hindbrain—Parkinson's disease	0.0256	0.12	CbGeAlD
Trametinib—MAP2K1—embryo—Parkinson's disease	0.016	0.0752	CbGeAlD
Trametinib—MAP2K1—brainstem—Parkinson's disease	0.0147	0.0689	CbGeAlD
Trametinib—MAP2K1—forebrain—Parkinson's disease	0.0142	0.0665	CbGeAlD
Trametinib—MAP2K2—forebrain—Parkinson's disease	0.0125	0.0585	CbGeAlD
Trametinib—MAP2K1—cardiovascular system—Parkinson's disease	0.012	0.0562	CbGeAlD
Trametinib—MAP2K2—cardiovascular system—Parkinson's disease	0.0105	0.0495	CbGeAlD
Trametinib—MAP2K1—spinal cord—Parkinson's disease	0.00912	0.0428	CbGeAlD
Trametinib—MAP2K2—medulla oblongata—Parkinson's disease	0.00901	0.0423	CbGeAlD
Trametinib—MAP2K2—midbrain—Parkinson's disease	0.00823	0.0387	CbGeAlD
Trametinib—MAP2K1—head—Parkinson's disease	0.00811	0.0381	CbGeAlD
Trametinib—MAP2K2—spinal cord—Parkinson's disease	0.00803	0.0377	CbGeAlD
Trametinib—MAP2K1—nervous system—Parkinson's disease	0.00769	0.0361	CbGeAlD
Trametinib—MAP2K1—central nervous system—Parkinson's disease	0.0074	0.0347	CbGeAlD
Trametinib—MAP2K1—cerebellum—Parkinson's disease	0.00723	0.034	CbGeAlD
Trametinib—MAP2K2—head—Parkinson's disease	0.00714	0.0335	CbGeAlD
Trametinib—MAP2K2—nervous system—Parkinson's disease	0.00677	0.0318	CbGeAlD
Trametinib—MAP2K2—central nervous system—Parkinson's disease	0.00652	0.0306	CbGeAlD
Trametinib—MAP2K2—cerebellum—Parkinson's disease	0.00637	0.0299	CbGeAlD
Trametinib—MAP2K1—brain—Parkinson's disease	0.00588	0.0276	CbGeAlD
Trametinib—MAP2K2—brain—Parkinson's disease	0.00517	0.0243	CbGeAlD
Trametinib—CYP2C8—brain—Parkinson's disease	0.00179	0.00841	CbGeAlD
Trametinib—CYP3A4—nervous system—Parkinson's disease	0.00159	0.00745	CbGeAlD
Trametinib—CYP3A4—central nervous system—Parkinson's disease	0.00153	0.00718	CbGeAlD
Trametinib—MAP2K2—Signaling Pathways—GRK5—Parkinson's disease	0.000258	0.000328	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by VEGF—IL6—Parkinson's disease	0.000256	0.000325	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—PARK2—Parkinson's disease	0.000255	0.000325	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—RIT2—Parkinson's disease	0.000255	0.000324	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by Insulin receptor—IL6—Parkinson's disease	0.000254	0.000323	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—FGF20—Parkinson's disease	0.000253	0.000322	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000252	0.00032	CbGpPWpGaD
Trametinib—MAP2K2—Disease—RPL23A—Parkinson's disease	0.000251	0.000319	CbGpPWpGaD
Trametinib—MAP2K2—Disease—RPL14—Parkinson's disease	0.000251	0.000319	CbGpPWpGaD
Trametinib—MAP2K2—MAPK Signaling Pathway—TNF—Parkinson's disease	0.00025	0.000318	CbGpPWpGaD
Trametinib—MAP2K1—Toll Like Receptor 4 (TLR4) Cascade—IL6—Parkinson's disease	0.000244	0.00031	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—ABL1—Parkinson's disease	0.000244	0.00031	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—GRK5—Parkinson's disease	0.000242	0.000307	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—PARK2—Parkinson's disease	0.000239	0.000304	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—FGF20—Parkinson's disease	0.000237	0.000301	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000235	0.000299	CbGpPWpGaD
Trametinib—MAP2K2—Regulation of toll-like receptor signaling pathway—IL6—Parkinson's disease	0.000235	0.000299	CbGpPWpGaD
Trametinib—MAP2K1—Disease—RPL23A—Parkinson's disease	0.000235	0.000298	CbGpPWpGaD
Trametinib—MAP2K1—Disease—RPL14—Parkinson's disease	0.000235	0.000298	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—TNF—Parkinson's disease	0.000234	0.000298	CbGpPWpGaD
Trametinib—MAP2K2—Disease—FGF20—Parkinson's disease	0.000234	0.000297	CbGpPWpGaD
Trametinib—MAP2K2—Disease—RPS8—Parkinson's disease	0.000234	0.000297	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—HTR1A—Parkinson's disease	0.000233	0.000297	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by SCF-KIT—IL6—Parkinson's disease	0.000232	0.000295	CbGpPWpGaD
Trametinib—MAP2K2—Toll-Like Receptors Cascades—IL6—Parkinson's disease	0.000232	0.000295	CbGpPWpGaD
Trametinib—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000232	0.000295	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—GRM4—Parkinson's disease	0.000232	0.000295	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—TAC1—Parkinson's disease	0.00023	0.000292	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—IL1B—Parkinson's disease	0.000229	0.000291	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000229	0.000291	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—DRD1—Parkinson's disease	0.000225	0.000286	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—CASP3—Parkinson's disease	0.000225	0.000286	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signaling of activated FGFR—IL6—Parkinson's disease	0.000222	0.000283	CbGpPWpGaD
Trametinib—MAP2K1—Regulation of toll-like receptor signaling pathway—IL6—Parkinson's disease	0.00022	0.000279	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PENK—Parkinson's disease	0.00022	0.000279	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MAG—Parkinson's disease	0.00022	0.000279	CbGpPWpGaD
Trametinib—MAP2K1—Disease—FGF20—Parkinson's disease	0.000219	0.000278	CbGpPWpGaD
Trametinib—MAP2K1—Disease—RPS8—Parkinson's disease	0.000219	0.000278	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB4—IL6—Parkinson's disease	0.000219	0.000278	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—HTR1A—Parkinson's disease	0.000218	0.000277	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—DRD3—Parkinson's disease	0.000218	0.000277	CbGpPWpGaD
Trametinib—MAP2K1—Toll-Like Receptors Cascades—IL6—Parkinson's disease	0.000217	0.000276	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by SCF-KIT—IL6—Parkinson's disease	0.000217	0.000276	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—GRM4—Parkinson's disease	0.000217	0.000276	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ND3—Parkinson's disease	0.000215	0.000274	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—MCCC1—Parkinson's disease	0.000215	0.000274	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000215	0.000273	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—TAC1—Parkinson's disease	0.000215	0.000273	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—IL1B—Parkinson's disease	0.000214	0.000273	CbGpPWpGaD
Trametinib—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000212	0.00027	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.000211	0.000269	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—DRD1—Parkinson's disease	0.000211	0.000268	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—CASP3—Parkinson's disease	0.00021	0.000267	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signal transduction—IL6—Parkinson's disease	0.000209	0.000266	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signaling of activated FGFR—IL6—Parkinson's disease	0.000208	0.000264	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR—IL6—Parkinson's disease	0.000208	0.000264	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB2—IL6—Parkinson's disease	0.000207	0.000263	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—MAPK8—Parkinson's disease	0.000207	0.000263	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 signaling—IL6—Parkinson's disease	0.000206	0.000262	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MAG—Parkinson's disease	0.000206	0.000261	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PENK—Parkinson's disease	0.000206	0.000261	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB4—IL6—Parkinson's disease	0.000205	0.00026	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—DRD3—Parkinson's disease	0.000204	0.00026	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000204	0.000259	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—OMD—Parkinson's disease	0.000203	0.000257	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—TALDO1—Parkinson's disease	0.000203	0.000257	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PDYN—Parkinson's disease	0.000201	0.000255	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—HTR7—Parkinson's disease	0.000197	0.000251	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—DRD2—Parkinson's disease	0.000197	0.000251	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signal transduction—IL6—Parkinson's disease	0.000196	0.000248	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—INS—Parkinson's disease	0.000195	0.000248	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—IL6—Parkinson's disease	0.000195	0.000247	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—IL6—Parkinson's disease	0.000194	0.000246	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—IL6—Parkinson's disease	0.000194	0.000246	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—IL6—Parkinson's disease	0.000194	0.000246	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—IL6—Parkinson's disease	0.000194	0.000246	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—MAPK8—Parkinson's disease	0.000193	0.000246	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—IL6—Parkinson's disease	0.000193	0.000245	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—NDUFB11—Parkinson's disease	0.000192	0.000244	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—IL6—Parkinson's disease	0.000192	0.000244	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000191	0.000242	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—IL6—Parkinson's disease	0.00019	0.000242	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—IL6—Parkinson's disease	0.000189	0.000241	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—GFAP—Parkinson's disease	0.000189	0.00024	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PDYN—Parkinson's disease	0.000188	0.000239	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—GRM5—Parkinson's disease	0.000187	0.000237	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—ADRBK1—Parkinson's disease	0.000186	0.000237	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—DRD2—Parkinson's disease	0.000185	0.000235	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—HTR7—Parkinson's disease	0.000185	0.000235	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GCH1—Parkinson's disease	0.000183	0.000233	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—INS—Parkinson's disease	0.000182	0.000232	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—IL6—Parkinson's disease	0.000181	0.00023	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—IL6—Parkinson's disease	0.000181	0.00023	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—IL6—Parkinson's disease	0.000181	0.00023	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—IL6—Parkinson's disease	0.00018	0.000228	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.000178	0.000227	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—IL6—Parkinson's disease	0.000178	0.000226	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.000177	0.000226	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—IL6—Parkinson's disease	0.000177	0.000225	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.000177	0.000225	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—GFAP—Parkinson's disease	0.000177	0.000225	CbGpPWpGaD
Trametinib—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.000176	0.000223	CbGpPWpGaD
Trametinib—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000175	0.000222	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—GRM5—Parkinson's disease	0.000175	0.000222	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—ADRBK1—Parkinson's disease	0.000174	0.000221	CbGpPWpGaD
Trametinib—MAP2K2—Disease—ADRBK1—Parkinson's disease	0.000172	0.000218	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—IL6—Parkinson's disease	0.000172	0.000218	CbGpPWpGaD
Trametinib—MAP2K2—Disease—HSPA1A—Parkinson's disease	0.000171	0.000217	CbGpPWpGaD
Trametinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000166	0.000211	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000165	0.00021	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—FGF20—Parkinson's disease	0.000164	0.000208	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—DBH—Parkinson's disease	0.000163	0.000207	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—FBP1—Parkinson's disease	0.000163	0.000207	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GBA—Parkinson's disease	0.000163	0.000207	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.000163	0.000207	CbGpPWpGaD
Trametinib—MAP2K1—Disease—ADRBK1—Parkinson's disease	0.000161	0.000204	CbGpPWpGaD
Trametinib—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000161	0.000204	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—IL6—Parkinson's disease	0.000161	0.000204	CbGpPWpGaD
Trametinib—MAP2K1—Disease—HSPA1A—Parkinson's disease	0.00016	0.000203	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ADORA2A—Parkinson's disease	0.000159	0.000202	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—EDN1—Parkinson's disease	0.000158	0.000201	CbGpPWpGaD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000155	0.000197	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—FGF20—Parkinson's disease	0.000153	0.000195	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—ABL1—Parkinson's disease	0.000152	0.000193	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000149	0.000189	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—EDN1—Parkinson's disease	0.000148	0.000188	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—INSR—Parkinson's disease	0.000147	0.000186	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HGF—Parkinson's disease	0.000143	0.000181	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—ABL1—Parkinson's disease	0.000142	0.00018	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—FGB—Parkinson's disease	0.000139	0.000176	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—HTR2A—Parkinson's disease	0.000138	0.000176	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HTR1A—Parkinson's disease	0.000138	0.000175	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—INSR—Parkinson's disease	0.000137	0.000174	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TAC1—Parkinson's disease	0.000136	0.000173	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—IL6—Parkinson's disease	0.000134	0.000171	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HGF—Parkinson's disease	0.000134	0.00017	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—DRD1—Parkinson's disease	0.000133	0.000169	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—IL6—Parkinson's disease	0.000132	0.000168	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—FGB—Parkinson's disease	0.00013	0.000165	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000129	0.000164	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HTR1A—Parkinson's disease	0.000129	0.000164	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—DRD3—Parkinson's disease	0.000129	0.000164	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TAC1—Parkinson's disease	0.000127	0.000161	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—IL6—Parkinson's disease	0.000126	0.00016	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—DRD1—Parkinson's disease	0.000125	0.000158	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—IL6—Parkinson's disease	0.000123	0.000157	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—DRD3—Parkinson's disease	0.000121	0.000153	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ADRBK1—Parkinson's disease	0.00012	0.000153	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—DDC—Parkinson's disease	0.00012	0.000152	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—IL6—Parkinson's disease	0.000119	0.000152	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—MAPK8—Parkinson's disease	0.000118	0.00015	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—DRD2—Parkinson's disease	0.000117	0.000148	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HTR7—Parkinson's disease	0.000117	0.000148	CbGpPWpGaD
Trametinib—MAP2K2—Disease—MTHFR—Parkinson's disease	0.000116	0.000148	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ND3—Parkinson's disease	0.000116	0.000147	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—MCCC1—Parkinson's disease	0.000116	0.000147	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GSTA4—Parkinson's disease	0.000113	0.000144	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000113	0.000143	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—IL6—Parkinson's disease	0.000112	0.000142	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000112	0.000142	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—MAPK8—Parkinson's disease	0.00011	0.00014	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—DRD2—Parkinson's disease	0.000109	0.000139	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HTR7—Parkinson's disease	0.000109	0.000139	CbGpPWpGaD
Trametinib—MAP2K1—Disease—MTHFR—Parkinson's disease	0.000109	0.000138	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—OMD—Parkinson's disease	0.000109	0.000138	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—TALDO1—Parkinson's disease	0.000109	0.000138	CbGpPWpGaD
Trametinib—MAP2K2—Disease—APOE—Parkinson's disease	0.000108	0.000138	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—TNF—Parkinson's disease	0.000106	0.000134	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	0.000103	0.000131	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PLA2G6—Parkinson's disease	0.000102	0.000129	CbGpPWpGaD
Trametinib—MAP2K1—Disease—APOE—Parkinson's disease	0.000101	0.000129	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—MAOB—Parkinson's disease	0.000101	0.000128	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—TNF—Parkinson's disease	9.88e-05	0.000126	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GCH1—Parkinson's disease	9.83e-05	0.000125	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IGF2—Parkinson's disease	9.77e-05	0.000124	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	9.6e-05	0.000122	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IGF1R—Parkinson's disease	9.45e-05	0.00012	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—EDN1—Parkinson's disease	9.34e-05	0.000119	CbGpPWpGaD
Trametinib—MAP2K2—Disease—INS—Parkinson's disease	9.26e-05	0.000118	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IGF2—Parkinson's disease	9.14e-05	0.000116	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IGF1R—Parkinson's disease	8.84e-05	0.000112	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GBA—Parkinson's disease	8.76e-05	0.000111	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—DBH—Parkinson's disease	8.76e-05	0.000111	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—FBP1—Parkinson's disease	8.76e-05	0.000111	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—EDN1—Parkinson's disease	8.74e-05	0.000111	CbGpPWpGaD
Trametinib—MAP2K1—Disease—INS—Parkinson's disease	8.67e-05	0.00011	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NGF—Parkinson's disease	8.58e-05	0.000109	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—IL6—Parkinson's disease	8.52e-05	0.000108	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HTR2A—Parkinson's disease	8.17e-05	0.000104	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NGF—Parkinson's disease	8.03e-05	0.000102	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—IL6—Parkinson's disease	7.97e-05	0.000101	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HTR2A—Parkinson's disease	7.64e-05	9.71e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—APOE—Parkinson's disease	7.59e-05	9.65e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—IL6—Parkinson's disease	7.53e-05	9.56e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP2D6—Parkinson's disease	7.5e-05	9.53e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL1B—Parkinson's disease	7.49e-05	9.51e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CTGF—Parkinson's disease	7.36e-05	9.35e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—APOE—Parkinson's disease	7.1e-05	9.03e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—IL6—Parkinson's disease	7.04e-05	8.95e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL1B—Parkinson's disease	7e-05	8.9e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—MAPK8—Parkinson's disease	6.87e-05	8.72e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP2E1—Parkinson's disease	6.86e-05	8.71e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—NQO1—Parkinson's disease	6.78e-05	8.62e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—TH—Parkinson's disease	6.68e-05	8.49e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—INS—Parkinson's disease	6.49e-05	8.24e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—DDC—Parkinson's disease	6.43e-05	8.17e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—MAPK8—Parkinson's disease	6.42e-05	8.16e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYCS—Parkinson's disease	6.42e-05	8.15e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GSTA4—Parkinson's disease	6.07e-05	7.72e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—INS—Parkinson's disease	6.07e-05	7.71e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—COMT—Parkinson's disease	5.68e-05	7.22e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GSTP1—Parkinson's disease	5.65e-05	7.19e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—MAOA—Parkinson's disease	5.64e-05	7.17e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—HMOX1—Parkinson's disease	5.58e-05	7.09e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	5.47e-05	6.95e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—MAOB—Parkinson's disease	5.41e-05	6.88e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ABCB1—Parkinson's disease	5.35e-05	6.8e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GSTM1—Parkinson's disease	5.2e-05	6.6e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GPX1—Parkinson's disease	4.98e-05	6.32e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CASP3—Parkinson's disease	4.83e-05	6.14e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL6—Parkinson's disease	4.8e-05	6.1e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—MTHFR—Parkinson's disease	4.59e-05	5.84e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CASP3—Parkinson's disease	4.52e-05	5.74e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL6—Parkinson's disease	4.49e-05	5.7e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MAPK8—Parkinson's disease	4.44e-05	5.64e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL6—Parkinson's disease	4.38e-05	5.57e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—APOE—Parkinson's disease	4.28e-05	5.43e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MAPK8—Parkinson's disease	4.15e-05	5.28e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL6—Parkinson's disease	4.1e-05	5.21e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—IL6—Parkinson's disease	4.05e-05	5.14e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	4.02e-05	5.11e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CTGF—Parkinson's disease	3.95e-05	5.02e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—IL6—Parkinson's disease	3.79e-05	4.81e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	3.68e-05	4.68e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—INS—Parkinson's disease	3.65e-05	4.64e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NQO1—Parkinson's disease	3.64e-05	4.62e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—TH—Parkinson's disease	3.59e-05	4.56e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYCS—Parkinson's disease	3.44e-05	4.38e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—COMT—Parkinson's disease	3.05e-05	3.88e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GSTP1—Parkinson's disease	3.04e-05	3.86e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—MAOA—Parkinson's disease	3.03e-05	3.85e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HMOX1—Parkinson's disease	2.99e-05	3.8e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ABCB1—Parkinson's disease	2.87e-05	3.65e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL6—Parkinson's disease	2.83e-05	3.6e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GSTM1—Parkinson's disease	2.79e-05	3.54e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GPX1—Parkinson's disease	2.67e-05	3.39e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL6—Parkinson's disease	2.65e-05	3.37e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—MTHFR—Parkinson's disease	2.47e-05	3.13e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOE—Parkinson's disease	2.29e-05	2.92e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—INS—Parkinson's disease	1.96e-05	2.49e-05	CbGpPWpGaD
